Ecosystem
ALONE YOU CAN DO SOMETHING, TOGETHER YOU CAN DO ANYTHING.
This belief drives us to foster robust, complementary partnerships. Our comprehensive ecosystem delivers expertise across development, clinical, regulatory, compliance, production, and distribution for pharma, biotech, and medical device companies.
Thanks to our strategic partnerships, we can extend our services and solutions in additional specialized areas, ensuring a well-rounded approach to meet your needs.
Ecosystem
Other companies in the QbD Group
QbD IVD | Qarad
Quercus
Scilife
Simabs
Antleron
SciencePharma
SciencePharma is a Polish company offering consulting and importing services for the pharmaceutical industry. Established in 2004, SciencePharma is a leader among Polish and foreign consulting companies, having successfully implemented national and international projects.
Over the past decade, SciencePharma has prepared over 820 dossiers for medicinal products and excels in drug development projects, importation, and GMP/GDP compliance. With a diverse and experienced team, SciencePharma provides holistic support from early-stage development through clinical trials and product lifecycle management.
In 2024, SciencePharma’s team of 120 specialists joined QbD Group, further strengthening its core competencies in regulatory compliance, CMC services, and product development support.
QbD Group Partner Companies
Blue Mountain
The Blue Mountain Regulatory Asset Manager® (Blue Mountain RAM) platform, designed exclusively for the Life Sciences industry, provides a fully validated out-of-the-box, cloud-based EAM solution combining equipment maintenance, calibration, and qualification features in a single, integrated package.
Our platform is best-in-class for asset maintenance and parts management, automated workflows, electronic signatures, powerful reporting, and robust audit trails to ensure GMP compliance across all sectors of the industry. Blue Mountain RAM is highly configurable to meet your needs, supported by a strong technical team with many years of diverse industry experience.
Timeseer
Pils
ISPE
Flanders.bio
Amelior
HollandBIO
European Social Fund
Pharma.be
QbD is a partner of pharma.be, the federation of the innovative biopharmaceutical industry in Belgium, represents over 130 companies and 35.000 employees active in human healthcare in Belgium.
As a full partner of physicians, pharmacists, hospitals, governments and other stakeholders, pharma.be has the mission to promote better health care through therapeutic innovation in the domain of medicinal products for human and veterinary use.
Healixia
BioWin
The BioWin competitiveness cluster brings together all the innovation system players in the field of health (biopharma and medtech) in Wallonia, with the goal of stimulating regional economic redeployment.
TOPRA
RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of professionals involved with regulatory and quality for healthcare products, including medical devices, pharmaceuticals and biologics, diagnostics, and digital health.
Founded in 1976 as a neutral, nonprofit organization, RAPS supports and elevates the regulatory profession with education and training, professional standards, publications, research, networking, career development, and other valuable resources.
RAPS is home to the Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. The society is headquartered in suburban Washington, D.C., with chapters and affiliates worldwide.
BIVDA
CANIFARMA
TEAM PRRC
EMWA
EAAR
The European Association of Authorised Representatives (EAAR) was established in 2002 in order to accurately represent organizations that provide European Authorised Representative services to non-European manufacturers of medical devices and in-vitro diagnostic medical devices.
Its purpose is also to maintain a dialogue with the European Commission, Competent Authorities, Notified Bodies and other European industry associations about the role of Authorised Representatives in the context of compliance with European medical device regulatory requirements.